Dmitry Shuster, MD
Gastroenterology · Springfield, ILNPI 1053623504
Payments from drug & device makers
Across 722 payments — averaging $1339.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim International GmbH$559K
- AbbVie$356K
- Madrigal Pharmaceuticals$40K
- Perspectum Diagnostics Ltd$6K
- Olympus Corporation Of The Americas$1K
- Boston Scientific$1K
- plus $3K from 18 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim International GmbH | 166 | $558,582 |
| AbbVie | 389 | $355,941 |
| Madrigal Pharmaceuticals | 30 | $40,190 |
| Perspectum Diagnostics Ltd | 9 | $6,357 |
| Olympus Corporation Of The Americas | 12 | $1,411 |
| Boston Scientific | 7 | $1,363 |
| Covidien LP | 8 | $1,014 |
| Takeda Pharmaceuticals U.S.A., Inc. | 41 | $660 |
| Endogastric Solutions, Inc | 5 | $648 |
| Johnson & Johnson(2 entities) | 30 | $598 |
| Sanofi | 6 | $202 |
| Regeneron Healthcare Solutions, Inc. | 3 | $72 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $68 |
| Bristol Myers Squibb | 3 | $43 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| Sandoz | 1 | $20 |
| Gilead | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Intercept Pharmaceuticals, Inc. | 1 | $18 |
| Ardelyx, Inc. | 1 | $17 |
| Olympus America Inc. | 1 | $17 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Amgen | 1 | $15 |
| Ambu Inc. | 1 | $12 |
How this compares
$967,322 in reported general payments places this provider in the 95th percentile of 787 gastroenterology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Springfield
- Kamran AyubOak Lawn$4.3M
- David RubinChicago$3.6M
- Jonathan RosenbergGurnee$3.1M
- Stephen HanauerChicago$2.9M
- Parambir DulaiChicago$2.2M
- Charles BerkelhammerOak Lawn$1.9M
- Ikuo HiranoChicago$1.8M
- Manish BhuvaLake Barrington$1.7M
- Steven FlammChicago$1.6M
- Amar NaikDes Plaines$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.